Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-18

Clinical Trial Update: Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of stiripentol in patients aged 6 years and older with Primary Hyperoxaluria types 1-3; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stiripentol (Diacomit) (stiripentol)

Snippet

Sponsor: Biocodex | Conditions: Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 | Phase 3 | Status: NOT_YET_RECRUITING